首页> 美国卫生研究院文献>other >Quantification of 5-methylcytosine 5-hydroxymethylcytosine and 5-carboxylcytosine from the blood of cancer patients by an Enzyme-based Immunoassay
【2h】

Quantification of 5-methylcytosine 5-hydroxymethylcytosine and 5-carboxylcytosine from the blood of cancer patients by an Enzyme-based Immunoassay

机译:通过基于酶的免疫测定法对癌症患者血液中的5-甲基胞嘧啶5-羟甲基胞嘧啶和5-羧基胞嘧啶进行定量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundGenome-wide aberrations of the classic epigenetic modification 5-methylcytosine (5mC), considered the hallmark of gene silencing, has been implicated to play a pivotal role in mediating carcinogenic transformation of healthy cells. Recently, three epigenetic marks derived from enzymatic oxidization of 5mC namely 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), have been discovered in the mammalian genome. Growing evidence suggests that these novel bases possess unique regulatory functions and may play critical roles in carcinogenesis.
机译:背景技术经典表观遗传修饰5-甲基胞嘧啶(5mC)的全基因组畸变,被认为是基因沉默的标志,被认为在介导健康细胞的致癌转化中起关键作用。最近,在哺乳动物基因组中发现了5mC的酶促氧化衍生的三个表观遗传标记,即5-羟甲基胞嘧啶(5hmC),5-甲酰基胞嘧啶(5fC)和5-羧基胞嘧啶(5caC)。越来越多的证据表明,这些新颖的碱基具有独特的调节功能,并可能在致癌作用中发挥关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号